In recent assessments, several Wall Street brokerages have extended favorable ratings to Birkenstock (BIRK.N), acknowledging the potential benefits stemming from the German luxury sandal manufacturer’s strategic investments in expanding production capacity, introducing new styles, and its established brand loyalty.
Birkenstock’s stock experienced a dip, falling to $35.83 shortly after its listing on October 11, trading below the IPO price of $46 per share. This trend, coupled with underwhelming post-debut performance from other companies like Arm Holdings, Instacart (CART.O), and Klaviyo (KVYO.N), tempered expectations for a resurgence in the U.S. IPO market.
The company’s shares, however, exhibited resilience, edging up nearly 1% to reach $41.54 on Monday. This uptick coincided with the commencement of coverage by numerous underwriters, including major institutions like J.P. Morgan and Goldman Sachs, following the conclusion of the mandatory quiet period.
Citigroup stood out as one of the most optimistic firms, setting a price target of $52, signaling a potential increase of over 26% from the most recent closing price. Jefferies closely followed with a target of $50, echoing their belief in the company’s potential.
Citing Birkenstock’s strong brand and dedicated customer base, analysts at Jefferies expressed confidence in the company’s ability to achieve robust top-line growth, maintain attractive profit margins, and expand into broader market segments.
Analysts at Telsey Advisory Group also offered a positive outlook, noting that Birkenstock has the opportunity to further diversify into various footwear categories, including orthopedics, professional wear, outdoor and active footwear, children’s shoes, home products, and sneakers.
As of the present, Birkenstock commands a market capitalization of approximately $7.7 billion, surpassing the $4.35 billion that L Catteron, a U.S. private-equity firm supported by French billionaire Bernard Arnault and his luxury goods conglomerate LVMH (LVMH.PA), paid to acquire a majority stake in the company in 2021.
However, not all analysts share the same level of optimism. BofA Global Research analyst Lorraine Hutchinson acknowledged Birkenstock’s strong brand and unique attributes but expressed reservations about achieving outsized growth given the recent favorable trends.
Morgan Stanley took a more cautious stance, assigning a price target of $41 and an “equal-weight” rating, indicating that most anticipated catalysts may already be reflected in the stock price.
Art Hogan, Chief Market Strategist at B. Riley Wealth, emphasized the importance of accurately pricing a niche consumer-facing company in the context of potential adjustments in consumer spending patterns.
